JSAM
LEGN icon

J. Safra Asset Management’s Legend Biotech LEGN Stock Holding History

J. Safra Asset Management’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.8K Sell
617
-246
-29% -$6.64K ﹤0.01% 338
2026
Q1 		$15.6K Buy
863
+660
+325% +$12.6K ﹤0.01% 331
2025
Q4 		$4.41K Hold
203
– – ﹤0.01% 447
2025
Q3 		$6.62K Buy
203
+2
+1% +$74 ﹤0.01% 288
2025
Q2 		$7.13K Buy
201
+9
+5% +$292 ﹤0.01% 322
2025
Q1 		$6.51K Buy
192
+164
+586% +$5.88K ﹤0.01% 305
2024
Q4 		$918 Hold
28
– – ﹤0.01% 313
2024
Q3 		$1.38K Buy
+28
New +$1.49K ﹤0.01% 269

Other funds holding LEGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.56% 1-Year Est. Return

J. Safra Asset Management's LEGN Position: Q2 2026 in Review

J. Safra Asset Management reduced its Legend Biotech (LEGN) stake by 29% in Q2 2026, selling an estimated $6.64K and leaving 617 shares worth $17.8K. The position accounts for ﹤0.01% of the portfolio, ranked #338.

J. Safra Asset Management first reported a position in LEGN in Q3 2024 and has held it in 8 quarters since. 219 funds tracked by Wall St. Rank hold LEGN as of Q2 2026.

  • J. Safra Asset Management held 617 shares of Legend Biotech worth $17.8K as of Q2 2026.
  • J. Safra Asset Management sold 246 Legend Biotech shares in Q2 2026, an estimated $6.64K.
  • Legend Biotech made up ﹤0.01% of J. Safra Asset Management's portfolio in Q2 2026, its #338 holding.
  • J. Safra Asset Management first reported a position in Legend Biotech in Q3 2024 and has held it in 8 quarters since.
  • 219 funds tracked by Wall St. Rank held Legend Biotech as of Q2 2026.

Based on J. Safra Asset Management's 13F filing for Q2 2026, filed 6 Aug 2026.